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Dlx3 is a homeodomain protein and is known to play a role
in development and differentiation of many tissues. Deletion
of four base pairs in DLX3 (NT3198) is causally related to
tricho-dento-osseous (TDO) syndrome (OMIM #190320), a
genetic disorder manifested by taurodontism, hair abnor-
malities, and increased bone density in the cranium. The
molecular mechanisms that explain the phenotypic charac-
teristics of TDO syndrome have not been clearly determined.
In this study, we examined phenotypic characteristics of
wild type DLX3 (wtDlx3) and 4-BP DEL DLX3 (TDO mtDlx3)
in C2C12 cells. To investigate how wtDlx3 and TDO mtDlx3
differentially regulate osteoblastic differentiation, reporter
assays were performed by using luciferase reporters containing
the promoters of alkaline phosphatase, bone sialoprotein or
osteocalcin. Both wtDlx3 and TDO mtDlx3 enhanced
significantly all the reporter activities but the effect of
mtDlx3 was much weaker than that of wtDlx3. In spite of
these differences in reporter activity, electrophoretic mobility
shift assay showed that both wtDlx3 and TDO mtDlx3
formed similar amounts of DNA binding complexes with
Dlx3 binding consensus sequence or with ALP promoter
oligonucleotide bearing the Dlx3 binding core sequence.
TDO mtDlx3 exhibits a longer half-life than wtDlx3 and it
corresponds to PESTfind analysis result showing that
potential PEST sequence was missed in carboxy terminal of
TDO mtDlx3. In addition, co-immunoprecipitation demonst-
rated that TDO mtDlx3 binds to Msx2 more strongly than
wtDlx3. Taken together, though TDO mtDlx3 acted as a
weaker transcriptional activator than wtDlx3 in osteoblastic
cells, there is possibility that during in vivo osteoblast
differentiation TDO mtDlx3 may antagonize transcriptional
repressor activity of Msx2 more effectively and for longer
period than wtDlx3, resulting in enhancement of osteoblast
differentiation.
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Introduction
Homeodomain (HD) proteins comprise a large group of
transcription factors and are essential regulators of many
developmental processes, ranging from organization of the
basic body to terminal differentiation of individual tissues
(McGinnis and Krumlauf, 1992). The binding sites of HD
proteins typically center around TAAT sequence motif and
adjacent bases are thought to impart specificity to interactions
between HD proteins and target genes (Scott et al., 1989;
Laughon, 1991). The Distal-less family (Dlx) is one of the
HD protein families. In vertebrates, there are six Dlx genes
arranged in three clusters (Dlx1/Dlx2, Dlx3/Dlx4, Dlx5/Dlx6;
Ghanem et al., 2003). Among these Dlx genes, the importance
of Dlx3 during development arises from several observations
of disease states. Mutations in DLX3 are believed to be
causally related to tricho-dento-osseous (TDO) syndrome
(OMIM #190320), a genetic disorder manifested by tauro-
dontism, hair abnormalities, and increased bone density in
the cranium (Price et al., 1998a, 1998b; Wright et al., 1997).
TDO syndrome is inherited as an autosomal dominant trait.
The genetic defect leading to TDO syndrome appears to be
associated with a four nucleotide deletion just downstream
of the HD (4-BP DEL, NT3198), resulting in frame shift and
premature truncation of the DLX3 protein.
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The promoter region of osteoblast differentiation marker
genes, such as alkaline phosphatase (ALP), osteocalcin (OCN)
and bone sialoprotein (BSP), contains multiple HD binding
motifs (Benson et al., 2000; Hassan et al., 2004; Kim et al.,
2004). In MC3T3-E1 cells, overexpression of Dlx3 induced
the expression of osteoblast differentiation maker genes
such as OCN and BSP while knockdown of Dlx3 by RNA
interference down-regulated (Hassan et al., 2004). In addition,
it has been suggested that the switching of HD proteins
occupancy to Runx2 or OCN promoters regulates the tran-
scription of these genes during osteoblast differentiation;
that is, Msx2 occupancy is associated with repression or
basal transcription but Dlx3 and/or Dlx5 occupancy is
associated with active transcription (Hassan et al., 2004,
2006). These reports suggest that Dlx3 is an important
osteogenic regulator. Since the phenotype of increased bone
density appears in some of TDO syndrome patients, we
examined the effects of wild type DLX3 (wtDlx3) or 4-BP
DEL DLX3 (TDO mtDlx3) overexpression on osteoblastic
differentiation using C2C12 cells. We demonstrated in this
study that i) both wtDlx3 and TDO mtDlx3 enhanced
osteoblast differentiation, ii) in spite of having similar DNA
binding affinity, TDO mtDlx3 acted as a weaker transc-
riptional activator than wtDlx3, iii) TDO mtDlx3 had a
longer half-life than wtDlx3, and iv) TDO mtDlx3 shows
stronger interaction with Msx2.
Materials and Methods
Cell culture
C2C12 and NIH3T3 cells were maintained in Dulbecco’s
modified Eagles medium (DMEM; Hyclone; Logan, UT,
USA) supplemented with 10% heat inactivated fetal bovine
serum (FBS; Hyclone) and antibiotics (100 units/ml penicillin
and 100 µg/ml streptomycin, Gibco BRL, Grand Island,
NY, USA). All the cell cultures were performed at 37oC in a
humidified atmosphere containing 5% CO2.
Transient transfection
Human full length wild type DLX3 ORF expression clone
(pReceiver-M12-wtDlx3) which contains N-terminal 3xFlag
tag was purchased from Genecopoeia (Germantown, Maryland,
USA) and sequence-verified. TDO mtDlx3 expression vector
was prepared by polymerase chain reaction (PCR)-amplified
site-directed mutagenesis cloning into pReceiver-M12
vector and sequence-verified as previously described (Cha
et al., 2007).
 For transient transfection, cells were plated at a density of
5×105 cells per 60  mm culture dish or 2×106 cells per
100 mm culture dish. After overnight incubation, cells were
serum-starved. Plasmid DNA (8 µg per 60 mm dish, 16 µg
per 100 mm dish) and Lipofectamine2000 (10 µl per 60 mm
dish, 20 µl per 100 mm dish; Invitrogen; Carlsbad, CA,
USA) were mixed and incubated for 20 minutes at room
temperature. DNA-Lipofectamine complex was diluted in
serum-free DMEM and added to serum-starved cells. After
4 hour incubation, culture medium was changed with
DMEM supplemented with 5% FBS. Twenty-four hours
after transfection, cells were used for experiments.
Immunoblot analysis and co-immunoprecipitation
After appropriate treatment, cells were washed with PBS
and scraped into lysis buffer consisted of 10 mM Tris-Cl
(pH 7.5), 150 mM NaCl, 1 mM EDTA (pH 8.0), 1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
sulfate (SDS), 50 mM NaF, 0.2 mM Na3VO4, 1 mM pheny-
lmethylsulphonylfluoride (PMSF), 1 µg/ml aprotinin, 1 µM
leupeptin and 1 µM pepstatin, and sonicated briefly. Protein
concentrations were determined using a modified Bradford
method (Bio-Rad Laboratories; Hercules, CA, USA). Samples
containing equal amounts of protein were subjected to SDS-
PAGE. The proteins separated in the gel were subsequently
transferred onto a polyvinylidene difluoride membrane. The
membrane was blocked with 5% nonfat dry milk in Tris-
buffered saline containing 0.1% Tween 20. Exogenously
expressed Dlx3 level was examined by using mouse anti-
Flag M2-HRP (Sigma-Aldrich; St. Louis, MO, USA). Actin
expression level was examined by using goat anti-Actin
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
followed by rabbit anti-goat HRP-conjugated IgG (Zymed;
San Francisco, CA, USA). Luminescence was detected by using
Supex reagent in a LAS1000 (Fuji PhotoFilm; Tokyo, Japan).
To examine the protein-protein interactions between
Msx2 and Dlx3, co-immunoprecipitation was performed.
Twenty-four hours after transfection with HA-tagged Msx2
and Flag-tagged Dlx3 expression vectors, C2C12 cells were
lysed with immunoprecipitation buffer consisted of 20 mM
Tris-Cl (pH 7.5), 150 mM NaCl, 1 mM EDTA (pH 8.0), 1%
Triton X-100, 0.5% sodium deoxycholate, 50 mM NaF, 1
mM PMSF, 0.2 mM Na3VO4, 1 µg/ml aprotinin, 1 µM
leupetin, and 1 µM pepstatin for 30 minutes at 4oC and
sonicated briefly. Samples containing equal amounts of protein
were incubated with 4-6 µg of anti-HA antibody with gentle
rocking overnight at 4oC. After adding protein G agarose
beads, the samples were incubated for 4 hours at 4oC with
gentle agitation. The bead pellet was washed five times with
immunoprecipitation buffer, denatured by boiling in 2x SDS
sample buffer including dithiothreitol, and then subjected to
SDS-PAGE and immunoblot analysis.
In vivo Dlx3 protein stability
Twenty-four hours after transfection with Dlx3 expression
plasmids, C2C12 cells were treated either with 5 µM MG132
(Calbiochem; La Jolla, CA, USA), a reversible proteasome
inhibitor or with 10 µg/ml cycloheximide (CHX; Sigma-
Aldrich), a protein synthesis inhibitor and incubated for the
times indicated. Then cell lysates were prepared with RIPA
buffer and immunoblot analysis was performed as described
above.
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Electrophoretic mobility shift assay (EMSA)
C2C12 and NIH3T3 cells were transiently transfected
with Dlx3 expression plasmids. After 24 hour incubation in
Opti-MEM supplemented with 5% FBS, nuclear extracts
were prepared by using NE-PER Nuclear and Cytoplasmic
Extraction Reagents (PIERCE Biotechnology; Rockford,
IL, USA) according to the manufacturer’s instruction. Two
sets of oligonucleotides were used for the EMSA; one is
from DNA sequence containing the Dlx3 binding site of
mouse ALP promoter (−511~−477) and the other is the Dlx3
consensus sequence. Oct-1 consensus sequence was used as
a negative control. The nucleotide sequences are as follows;
ALP promoter Dlx3 binding site sense strand 5'-GTCCC
TGTTTCTTCAGATATTAGGGAGGGAGGGCCCTG-3',
Dlx3 consensus sequence forward 5'-AGCTAGTGGTAA
TTGCTCAGA-3' and Oct-1 consensus sequence forward
5'-TGTCGAATGCAAATCACTAGAA-3'. They were end
labeled by using [32P]γdATP and T4 polynucleotide kinase
(Roche). Annealing of sense and antisense oligonucleotides
was performed by boiling for 5 minutes and slow cooling to
room temperature. Unincorporated nucleotides were removed
using NICK column Sephadex G-50 DNA Grade (GE
Health care; Buckinghamshire, UK). EMSA reaction mixtures
were prepared by mixing of 2 pmol of probe, 25 mM
HEPES, 1 mM EDTA, 0.5 mM dithiothreitol, 10% glycerol,
0.05% NP-40, 0.5 mM PMSF, 2 µg of poly(dI-dC) and 4 µg
of nuclear protein. In some tubes, unlabeled double-stranded
competitor oligonucleotides (50-fold molar excess over probe)
were added to the reaction mixtures. After 20 minutes
incubation at 22oC, reaction products were loaded onto 4%
polyacrylamide gel in 0.5X Tris-borate EDTA buffer and
ran for 1 hour at 200 V. Gels were vacuum-dried, exposed to
Medical X-ray Film Blue (AGFA; Mechelen, Belgium) and
incubated in the −80oC for 2 days. Then film was developed
and band intensity was observed by autoradiography.
Reporter assay
C2C12 cells were transiently transfected with Dlx3
expression vector or empty vector (500 ng per 4×104 cells),
luciferase reporter plasmid (1 µg per 4×104 cells) and
Renilla luciferase plasmid (phRL-TK; Promega; 200 ng per
4×104 cells) by using Microporator MP-100 (Digital Bio
Technology; Suwon, Korea) and microporation solution kit
(Digital Bio Technology) following manufacturer’s protocol.
Each luciferase reporter plasmid contains one of following
promoter region of mouse genes; 1.05 kb OCN promoter,
2.5 kb BSP promoter, 1.9 kb or 0.5 kb ALP promoter. BSP
promoter was kindly provided by Dr. G. Xiao (University of
Pittsburgh). Electroporation was performed at the condition of
pulse voltage of 1650 V, pulse width of 10 msec and pulse
number of 3. Then the cells were seeded at a density of 4×
104 cells/well in 96-well plates with clear bottom (Corning
Inc. Life Science; Lowell, MA, USA). After a twenty-four
hours incubation, the luciferase activity was measured by
using Dual-Glo Luciferase Assay System (Promega;
Madison, WI, USA). Relative luciferase activity was
calculated after normalizing the transfection efficiency by
Renilla luciferase expression level.
Results and Discussion
Both wtDlx3 and TDO mtDlx3 transactivated osteoblast
differentiation marker genes expression but transacti-
vational potential of TDO mtDlx3 was lower than that of
wtDlx3
Previous studies have shown that the knock-down of Dlx3
causes blockade of mature osteoblast formation by suppressing
bone related marker genes, indicating the critical role of
Dlx3 in osteoblastogensis (Hassan et al., 2004, 2006). Since
TDO mtDlx3 is known to be associated with autosomal
dominant TDO syndrome, comparing the properties of wtDlx3
and TDO mtDlx3 would be important for understanding the
molecular pathogenetic mechanism of TDO syndrome bone
phenotype.
Osteoblast differentiation marker genes such as ALP,
OCN and BSP are known to be regulated by HD tran-
scription factors (Benson et al., 2000; Hassan et al., 2004;
Kim et al., 2004). Promoter regions of ALP (1.9 kb), BSP
and OCN used in this study, have five putative HD binding
sites while ALP reporter of shorter size (553 bp) includes
Fig. 1. Overexpression of wtDlx3 strongly enhanced the transcrip-
tion of osteoblast differentiation marker genes while the effect of
TDO mtDlx3 was much weaker than that of wtDlx3. C2C12 cells
were transiently transfected with Dlx3 expression or pcDNA3.1
(Ctrl) vectors and luciferase reporter vectors containing 1.9 kb ALP
promoter (A), 0.5 kb ALP promoter (B), 2.5 kb BSP promoter (C)
or 1.05 kb OCN promoter (D). After 24 hour incubation, luciferase
activity was measured and transfection efficiency was normalized
by co-transfected Renilla luciferase activity. Data represent mean
+S.D. (N = 10). * significant difference from the control (p＜0.01),
# significant difference from wtDlx3 (p＜ 0.01).
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one putative Dlx3 binding site. Both wtDlx3 and TDO
mtDlx3 enhanced significantly ALP, BSP and OCN reporter
activity (Fig. 1). However, wtDlx3 transactivated ALP
promoters more strongly than TDO mtDlx3. These results
suggest that the region carboxyl to the HD of Dlx3 that is
frame-shifted in TDO mtDlx3, may be important to transac-
tivation by Dlx3 of osteoblast differentiation marker genes.
TDO mtDlx3 shows similar DNA binding affinity to
wtDlx3
Since TDO mtDlx3 exhibited much lower reporter activity
than wtDlx3, we examined whether there was any difference
in DNA binding affinity between wtDlx3 and mtDlx3. We
performed EMSA with oligonucleotides consisted of Dlx3
binding consensus sequence or of ALP promoter sequence
including the core sequence (−492 and −487). Nuclear
extracts from C2C12 or NIH3T3 cells which were transiently
transfected with wtDlx3 or TDO mtDlx3 expression plasmids,
were used as the sources of wtDlx3 and mtDlx3 proteins.
NIH3T3 does not express endogenous Dlx3 (Park and
Morasso, 1999). The radiolabeled ALP promoter probe as
well as radiolabeled Dlx3 consensus probe formed binding
complexes with the wtDlx3 and TDO mtDlx3 and these
complexes disappeared in the presence of fifty-fold excess
of unlabeled ALP probe and Dlx3 consensus probe (Fig. 2).
As expected from the fact that TDO mtDlx3 contains intact
HD, there was no remarkable difference in DNA binding
affinity between wtDlx3 and TDO mtDlx3. This result
indicates that reduced reporter activity in TDO mtDlx3-
transfected cells is not due to reduced DNA binding but may
be due to reduced transactivation potential of mtDlx3, and
that carboxyl-terminal region to HD of Dlx3 is not related to
DNA binding but may possess more important roles for
transcriptional activation through protein-protein interactions.
Outside of the HD domain, Dlx family proteins share
limited regions of similarity. For instance, all Dlx proteins
possess at least two tryptophan residues that are carboxyl to
HD and these tryptophans were suggested to be possible
sites for interaction with other proteins such as PBC-family
cofactors (Panganiban and Rubenstein, 2002). In addition,
Dlx proteins are proline-rich both upstream and downstream
of HD and these proline-rich domains have been implicated
with transcriptional activation function of Dlx3 (Feledy et
al., 1999). Therefore, lower transcriptional activation by
TDO mtDlx3 might be related to change in carboxyl terminal
amino acids that results in lack of these tryptophan residues
and proline-rich domains.
TDO mtDlx3 protein has a longer half-life than wtDlx3
Although overexpression of TDO mtDlx3 in C2C12 cells
induced osteoblast differentiation marker genes expression,
it was to a much lesser extent than that of wtDlx3 and it
looks like the opposite of in vivo bone phenotype of TDO
syndrome which exhibits increased bone density. Previously
we reported that wtDlx3 overexpression enhanced expression
of the receptor activator of nuclear factor-κB ligand (RANKL)
in bone morphogenetic protein 2-treated C2C12 cells while
TDO mtDlx3 did not (Cha et al., 2007). Since RANKL is a
critical osteoclastogenic cytokine (Lacey et al., 1998),
inability of TDO mtDlx3 to regulate expression of RANKL
may contribute to increased bone density in TDO syndrome
patients. Other possible explanation for this contradiction
might be a longer half-life of TDO mtDlx3 in vivo. PEST
domain is known as a proteolytic signal for degradation
through 26S proteasome (Rogers et al., 1986; Rechsteiner
and Rogers, 1996). PESTfind analysis has revealed that
wtDlx3 contains one potential PEST sequence and several
poor PEST sequences (Fig. 3A). To test whether Dlx3
protein is degraded by proteasome or not, C2C12 cells were
transiently transfected with wtDlx3 expression vectors and
incubated in the presence of MG132, a proteasome inhibitor.
In the presence of MG132, the amount of wtDlx3 protein
increased (Fig. 3B), indicating that Dlx3 proteins are
degraded through proteasome-dependent pathway. Since
PESTfind analysis result showed that potential PEST
sequence and one of poor PEST sequences of wtDlx3 were
lost in carboxyl terminal region of TDO mtDlx3 (Fig. 3A), it
was expected that degradation rate of mtDlx3 might be
slower than that of wtDlx3. Indeed, when the cells were
incubated in the presence of CHX, an inhibitor of protein
synthesis, the level of wtDlx3 protein diminished drastically
while mtDlx3 decreased more slowly than wtDlx3 (Fig.
3C). Densitometry analysis showed that the half-life of
wtDlx3 was much shorter than that of TDO mtDlx3. These
results suggest that deleted PEST sequences in TDO
mtDlx3 may play a role as a part of the regulatory sequences
for proteasomal degradation of Dlx3 protein. Since Dlx3
expression is not constitutive but is temporally regulated
during osteoblast differentiation (Hassan et al., 2004), TDO
mtDlx3 may stimulate the expression of osteoblast differen-
Fig. 2. wtDlx3 and TDO mtDlx3 showed similar DNA binding
affinity. EMSA was performed using radiolabeled oligonucleotides
consisted of ALP promoter sequence containing Dlx3 binding ele-
ment or of Dlx3 consensus sequence and nuclear extracts of C2C12
(A) or NIH3T3 cells (B) overexpressing wtDlx3 and TDO mtDlx3.
Competitor; Excess amounts of non-labeled probes (x 50) were
added to the binding reaction.
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tiation marker genes for longer period than wtDlx3 in vivo,
covering up the weak transactivational potential.
TDO mtDlx3 has higher binding affinity to Msx2 than
wtDlx3
Another possibility is that mtDlx3 might antagonize the
action of transcriptional repressors for longer period. One of
possible transcriptional repressor candidates is Msx proteins.
Previous reports have shown that Dlx binds to Msx and
antagonizes transcription regulatory activity of Msx (Zhang
et al., 1997). In addition, it was reported that Msx2 binds
competitively to the same DNA sites that Dlx3 binds and
that Msx2 occupied the transcriptionally repressed promoters
of ALP, Runx2 or OCN while Dlx3 and Dlx5 replaced Msx2
in transcriptionally active promoters (Kim et al., 2004;
Hassan et al., 2004, 2006). Since EMSA results showed that
Fig. 3. TDO mtDlx3 has longer half-life than wtDlx3. (A) Sequence analysis result of PEST domain finder shows that potential PEST
sequence and one of poor PEST sequence of wtDlx3 were removed by frame shift in TDO mtDlx3. (B, C) C2C12 cells were transiently trans-
fected with Dlx3 expression plasmids and incubated for 24 hours. Then cells were incubated in the presence of 5 µM MG132 (B) or 10 µg/ml
cycloheximide (CHX) for the times indicated and Dlx3 protein level was determined by immuno blot analysis. Densitometry results showed
that slope of wtDlx3 degradation was steeper than that of TDO mtDlx3 (C, right panel).
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wtDlx3 and TDO mtDlx3 had similar DNA binding affinity
(Fig. 2), it is suggested that both Dlx3 proteins may show
similar ability to compete with Msx2 for cis-acting elements
binding in these promoters. Therefore, we examined whether
there was any difference between wtDlx3 and mtDlx3 in
binding affinity to Msx2. Co-immunoprecipitation result
demonstrated that Dlx3 interacted with Msx2 (Fig. 4, left).
Although the amounts of wtDlx3 and TDO mtDlx3 used for
immunoprecipitation with anti-HA antibody were similar
(Fig. 4, right), the amount of Dlx3 co-immunoprecipitated
with Msx2 was larger in mtDlx3 than in wtDlx3. Though
previous report had shown that Dlx and Msx dimerize
through HDs (Bryan and Morasso, 2000), our data suggest
that carboxyl terminal region to HD of Dlx3 may be
involved in the regulation of dimerization. In addition, these
results suggest that during in vivo osteoblast differentiation
TDO mtDlx3 may antagonize transcriptional repressor
activity of Msx2 more effectively and for longer period than
wtDlx3, resulting in enhancement of osteoblast differentiation.
 During the preparation of this manuscript, one report has
been published showing that TDO mtDlx3 further enhanced
osteoblastic differentiation and mineralized nodule formation
in MC3T3-E1 and C2C12 cells than wtDlx3 did (Choi et al.,
2007). In their report, TDO mtDlx3 induced significantly
higher OCN promoter activity than wtDlx3 while the effect
of mtDlx3 on type I collagen promoter were similar to or
slightly lower than that of wtDlx3. The reason for the
discrepancy between their results and ours is not clear now.
One possibility is that they performed reporter assays with
cloned cells that stably express wtDlx3 or mtDlx3 while we
used transiently transfected cells. Further study will be
needed to define the clear figure of in vivo behavior of TDO
mtDlx3.
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